Shrutidevi Agrawal

672 total citations
13 papers, 561 citations indexed

About

Shrutidevi Agrawal is a scholar working on Infectious Diseases, Pharmaceutical Science and Oncology. According to data from OpenAlex, Shrutidevi Agrawal has authored 13 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Pharmaceutical Science and 5 papers in Oncology. Recurrent topics in Shrutidevi Agrawal's work include Tuberculosis Research and Epidemiology (5 papers), Drug Transport and Resistance Mechanisms (5 papers) and Drug Solubulity and Delivery Systems (5 papers). Shrutidevi Agrawal is often cited by papers focused on Tuberculosis Research and Epidemiology (5 papers), Drug Transport and Resistance Mechanisms (5 papers) and Drug Solubulity and Delivery Systems (5 papers). Shrutidevi Agrawal collaborates with scholars based in India and United States. Shrutidevi Agrawal's co-authors include Ramesh Panchagnula, Omathanu Pillai, Prasad V. Bharatam, C. L. Kaul, Inderjit Singh, Nuggehally R. Srinivas, Ramesh Mullangi, Manthena V. S. Varma, Sateesh Khandavilli and Rajesh Gandhi and has published in prestigious journals such as International Journal of Pharmaceutics, Journal of Pharmaceutical Sciences and European Journal of Pharmaceutical Sciences.

In The Last Decade

Shrutidevi Agrawal

13 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shrutidevi Agrawal India	10	219	119	96	89	87	13	561
Doo‐Man Oh United States	10	301 1.4×	139 1.2×	76 0.8×	144 1.6×	94 1.1×	13	645
T. Thanga Mariappan India	19	216 1.0×	76 0.6×	90 0.9×	119 1.3×	92 1.1×	32	776
Richard Lloyd United Kingdom	9	217 1.0×	130 1.1×	34 0.4×	232 2.6×	117 1.3×	12	740
Mario A. Quevedo Argentina	14	137 0.6×	85 0.7×	109 1.1×	153 1.7×	84 1.0×	39	519
Kwame Nti-Addae United States	8	163 0.7×	89 0.7×	56 0.6×	181 2.0×	52 0.6×	10	528
D.W. Groot Sweden	15	270 1.2×	106 0.9×	34 0.4×	85 1.0×	89 1.0×	21	541
Daniel Mufson United States	11	240 1.1×	124 1.0×	65 0.7×	75 0.8×	74 0.9×	20	522
Nishi Sharda India	10	102 0.5×	39 0.3×	69 0.7×	67 0.8×	90 1.0×	10	375
Marc Lindenberg Switzerland	7	491 2.2×	231 1.9×	44 0.5×	122 1.4×	130 1.5×	7	825
Sheeba Varghese Gupta United States	12	120 0.5×	66 0.6×	63 0.7×	187 2.1×	38 0.4×	23	654

Countries citing papers authored by Shrutidevi Agrawal

Since Specialization

Citations

This map shows the geographic impact of Shrutidevi Agrawal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shrutidevi Agrawal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shrutidevi Agrawal more than expected).

Fields of papers citing papers by Shrutidevi Agrawal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shrutidevi Agrawal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shrutidevi Agrawal. The network helps show where Shrutidevi Agrawal may publish in the future.

Co-authorship network of co-authors of Shrutidevi Agrawal

This figure shows the co-authorship network connecting the top 25 collaborators of Shrutidevi Agrawal. A scholar is included among the top collaborators of Shrutidevi Agrawal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shrutidevi Agrawal. Shrutidevi Agrawal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Mullangi, Ramesh, Shrutidevi Agrawal, & Nuggehally R. Srinivas. (2008). Measurement of xenobiotics in saliva: is saliva an attractive alternative matrix? Case studies and analytical perspectives. Biomedical Chromatography. 23(1). 3–25. 38 indexed citations

Panchagnula, Ramesh, et al.. (2008). A decision tree for rapid quality assurance and control of rifampicin-containing oral dosage forms for global distribution for tuberculosis treatment. Indian Journal of Pharmaceutical Sciences. 70(1). 1–1. 3 indexed citations

Singh, Inderjit, et al.. (2008). In Vivo Dissolution: Predominant Factor Affecting the Bioavailability of Rifampicin in its Solid Oral Dosage Forms. Clinical Research and Regulatory Affairs. 25(1). 1–12. 6 indexed citations

Agrawal, Shrutidevi & Ramesh Panchagnula. (2005). Implication of biopharmaceutics and pharmacokinetics of rifampicin in variable bioavailability from solid oral dosage forms. Biopharmaceutics & Drug Disposition. 26(8). 321–334. 51 indexed citations

Panchagnula, Ramesh, et al.. (2004). Solid-state characterization of mefenamic acid. Journal of Pharmaceutical Sciences. 93(4). 1019–1029. 58 indexed citations

Panchagnula, Ramesh & Shrutidevi Agrawal. (2004). Biopharmaceutic and pharmacokinetic aspects of variable bioavailability of rifampicin. International Journal of Pharmaceutics. 271(1-2). 1–4. 54 indexed citations

Agrawal, Shrutidevi, et al.. (2004). Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels. International Journal of Pharmaceutics. 276(1-2). 41–49. 55 indexed citations

Varma, Manthena V. S., Sateesh Khandavilli, Amit Jain, et al.. (2004). Biopharmaceutic Classification System: A Scientific Framework for Pharmacokinetic Optimization in Drug Research. Current Drug Metabolism. 5(5). 375–388. 79 indexed citations

Agrawal, Shrutidevi, et al.. (2004). Solid-state characterization of rifampicin samples and its biopharmaceutic relevance. European Journal of Pharmaceutical Sciences. 22(2-3). 127–144. 124 indexed citations

10.

Agrawal, Shrutidevi & Ramesh Panchagnula. (2004). Dissolution test as a surrogate for quality evaluation of rifampicin containing fixed dose combination formulations. International Journal of Pharmaceutics. 287(1-2). 97–112. 33 indexed citations

11.

Panchagnula, Ramesh, et al.. (2003). In vitro evaluation of food effect on the bioavailability of rifampicin from antituberculosis fixed dose combination formulations. Il Farmaco. 58(11). 1099–1103. 13 indexed citations

12.

Agrawal, Shrutidevi, et al.. (2002). Assessment of bioequivalence of rifampicin, isoniazid and pyrazinamide in a four drug fixed dose combination with separate formulations at the same dose levels. International Journal of Pharmaceutics. 233(1-2). 169–177. 41 indexed citations

13.

Agrawal, Shrutidevi, et al.. (2001). Antituberculosis drugs and new drug development. Current Opinion in Pulmonary Medicine. 7(3). 142–147. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact